Avantor to Engage at RBC Capital Markets Global Healthcare Conference
Avantor, Inc. (NYSE: AVTR), a prominent global provider of essential products and services for the life sciences and advanced technology sectors, is excited to announce its participation in the RBC Capital Markets Global Healthcare Conference. The firm's Executive Vice President and Chief Financial Officer, Brent Jones, will take the stage for a fireside chat during this prestigious event.
Details of the Conference Participation
The fireside chat is scheduled to take place during the conference in New York, where Brent Jones will share insights about Avantor's strategic initiatives. Attendees can look forward to hearing about Avantor's commitment to innovation in the life sciences industry, along with its roadmap for future growth and investment opportunities.
While the exact timing of the session will be announced, it's expected that the discussion will begin at approximately 8:00 a.m. Eastern Time. This participation symbolizes Avantor's dedication to fostering dialogue within the healthcare community and showcasing its role in advancing scientific research.
Live Streaming and Presentation Availability
For those unable to attend the live event, Avantor will provide access to a webcast of the chat. Interested investors and stakeholders are encouraged to visit the Events & Presentations section within the Investor Relations area of Avantor’s official website. Here, they can view the presentation slides in real time and engage with the live audio stream.
After the session concludes, the archived presentation materials will also be accessible on the website for a duration of 30 days. This will allow stakeholders to catch up on key points discussed and understand Avantor's strategic direction moving forward.
About Avantor
Avantor is a leader in the life sciences tools sector, specializing in providing mission-critical products to support significant advances in various scientific fields. The company's comprehensive portfolio supports research, development, and production activities at over 300,000 customer locations worldwide, spanning across 180 countries.
Avantor's relentless focus on customer collaboration as well as its dedication to scientific progress positions it as a trusted partner in enabling innovations in medicine, healthcare, and technology. Through its extensive global network and superior product offerings, Avantor continues to make strides in helping scientists and researchers achieve groundbreaking discoveries.
Contact Information for Investors and Media
For further inquiries regarding investor relations, Allison Hosak serves as the Senior Vice President of Global Communications at Avantor. She is available at 908-329-7281 for any questions related to investment and corporate communications.
For media inquiries, please reach out to Eric Van Zanten, the Head of External Communications at Avantor, at 610-529-6219. Avantor is committed to maintaining transparency and open communication with both its investors and the media.
Staying Connected
Avantor encourages everyone to keep up with its latest developments and initiatives by visiting the corporate website. Followers can also follow Avantor on LinkedIn, X (formerly Twitter), and Facebook to get real-time updates and engage with the Avantor community.
Frequently Asked Questions
What is the purpose of Avantor's participation in the conference?
Avantor aims to showcase its innovative strategies and connect with stakeholders in the healthcare industry.
Who will represent Avantor at the RBC Conference?
Brent Jones, the Executive Vice President and Chief Financial Officer, will represent Avantor at the conference.
How can I access the presentation from the event?
Presentation slides and a live audio webcast will be available on Avantor's Investor Relations website during the event.
What key topics will be discussed during the session?
The session will cover Avantor's strategic initiatives, innovation, and growth opportunities within the life sciences sector.
Where is Avantor located?
Avantor operates globally, serving customers across 180 countries in the life sciences and advanced technology industries.
